Introducing Chronos: The New Standard In Regenerative Aesthetics

In the ever-evolving landscape of regenerative aesthetics, where innovation meets precision, Cartessa Aesthetics is proud to introduce Chronos, the groundbreaking exosome treatment and advanced biologics brand that sets a new industry standard. 

What Sets Chronos Apart?

With a commitment to traceability, purity, and potency, Chronos represents a new leap forward for exosome technology, formulated in state-of-the-art labs of the highest scientific caliber to provide unparalleled results.

At the core of the Chronos brand is a dedication to delivering the highest quality and potency available. Crafted in an FDA-compliant, ISO 7, cGMP-certified lab, practitioners can trust they are offering a safe and effective solution for their patients. 

Cartessa partnered with a New York-based lab with a long history of developing pharmaceutical-grade products, further emphasizing the company’s commitment to excellence. The ISO-7-certified facility not only adheres to the highest safety and compliance standards but also provides detailed reports with each shipment - known as the Chronos Dossier, ensuring transparency and confidence in the product.

“We didn’t want to be the first-to-market with an exosome product. We wanted to be the best-to-market with an exosome product in the aesthetic space,” shared Gabe Lubin, Cartessa Aesthetics’ Founder and CEO. 

“Therefore, our team made a significant investment to determine what product would fill an unmet need and to select the right partner with the scientific know-how and in-house capabilities to develop it,” Lubin added.

The lead product, ExoCR, exemplifies this commitment with its unique characteristics.

How Is Exo CR Revolutionizing Regenerative Aesthetics?

ExoCR, the pioneer product of the Chronos portfolio, is a single-source, non-lyophilized, and highly active biologic specially formulated to target dermal fibroblasts.

“Since inception we vet products based on our three-point criteria to ensure they deliver a true advantage in terms of efficacy, patient experience and return,” said Lubin. “With Chronos ExoCR, we applied a fourth category—standards of compliance.”

Selecting the right source of exosomes for Chronos ExoCR was pivotal, and Wharton’s jelly, found within the umbilical cord and rich in exosomes, growth factors, and cytokines, emerged as the optimal choice. This perinatal tissue, sourced from umbilical cord donors, undergoes rigorous testing for safety from endotoxins, as well as ensuring the presence of crucial elements like mRNA, miRNA, and cytokines.

Boasting an impressive composition of more than 50 billion particulates, 10 billion intact exosomes, and over 1000 growth factors and cytokines, ExoCR offers the highest level of targeted potency available on the market.

A significant investment and nearly a year of development culminated in the creation of Chronos ExoCR, which stands as a testament to Cartessa's dedication to addressing the unmet needs in the aesthetics space.

“This range of post-treatment products makes a lot of sense in our portfolio of lasers and other energy-based technologies given how our devices work and Cartessa’s goal to continue to offer innovations that improve the patient experience,” said Crystal Romano, Cartessa’s President of Emerging Technologies.

Why Should You Consider Chronos for Your Practice? 

“As a company, we are always looking closely at trends. We think that exosomes and similar biologics are here to stay,” said Lubin. “There is still a long runway when it comes to developing and commercializing exosome-based products in aesthetics. We are in front of this trend and confident that Chronos products like ExoCR will completely change the exosome space in our industry.”

Embark on a new era of exosome technology with Chronos ExoCR. This advanced biologic, created from minimally manipulated Wharton’s Jelly, maintains superior quality, potency, and purity, ensuring optimal outcomes. 

Chronos ExoCR is now available for pre-order so what are you waiting for? 

Join Cartessa in setting a new benchmark in regenerative aesthetics, offering your patients a transformative experience like never before.